With over 33,000 employees worldwide, production plants in 13 countries and annual sales of over $22 billion worldwide, Eli Lilly and Company is one of the largest pharmaceutical companies in the world. It was founded in Indianapolis in 1876 by the pharmacologist, officer and entrepreneur Eli Lilly.
According to Eli Lilly's latest financial reports the company's current revenue (TTM ) is $49.00 Billion USD. In 2024 the company made a revenue of $45.04 Billion USD an increase over the revenue in the year 2023 that were of $34.12 Billion USD. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2025 (TTM) | $49.00 B | 8.79% |
2024 | $45.04 B | 32% |
2023 | $34.12 B | 19.56% |
2022 | $28.54 B | 0.79% |
2021 | $28.31 B | 15.4% |
2020 | $24.53 B | 9.95% |
2019 | $22.31 B | 0.11% |
2018 | $22.29 B | -2.52% |
2017 | $22.87 B | 7.77% |
2016 | $21.22 B | 6.33% |
2015 | $19.95 B | 1.75% |
2014 | $19.61 B | -15.13% |
2013 | $23.11 B | 2.25% |
2012 | $22.60 B | -6.93% |
2011 | $24.28 B | 5.25% |
2010 | $23.07 B | 5.68% |
2009 | $21.83 B | 7.15% |
2008 | $20.37 B | 9.36% |
2007 | $18.63 B | 18.75% |
2006 | $15.69 B | 7.14% |
2005 | $14.64 B | 5.68% |
2004 | $13.85 B | 10.14% |
2003 | $12.58 B | 13.59% |
2002 | $11.07 B | -4.03% |
2001 | $11.54 B | 6.26% |
2000 | $10.86 B | 8.59% |
1999 | $10.00 B | 15.57% |
1998 | $8.65 B | 1.62% |
1997 | $8.51 B | 15.94% |
1996 | $7.34 B |
Company | Revenue | Revenue differencediff. | Country |
---|---|---|---|
![]() Bristol-Myers Squibb BMY | $47.63 B | -2.79% | ๐บ๐ธ USA |
![]() Merck MRK | $63.92 B | 30.44% | ๐บ๐ธ USA |
![]() Johnson & Johnson JNJ | $89.33 B | 82.30% | ๐บ๐ธ USA |
![]() Pfizer PFE | $62.46 B | 27.47% | ๐บ๐ธ USA |
![]() Sanofi SNY | $47.39 B | -3.28% | ๐ซ๐ท France |
![]() GlaxoSmithKline GSK | $40.58 B | -17.18% | ๐ฌ๐ง UK |
![]() AbbVie ABBV | $57.36 B | 17.07% | ๐บ๐ธ USA |
![]() Amgen AMGN | $34.12 B | -30.36% | ๐บ๐ธ USA |
![]() Novartis NVS | $53.22 B | 8.61% | ๐จ๐ญ Switzerland |
![]() AstraZeneca AZN | $54.98 B | 12.20% | ๐ฌ๐ง UK |